Pineocytoma
Symptoms, Doctors, Treatments, Advances & More

Learn About Pineocytoma

What is the definition of Pineocytoma?
A Pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Signs and symptoms of Pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body.
What are the alternative names for Pineocytoma?
  • Pineocytoma
  • Pinealocytoma
  • Pinealoma
Who are the top Pineocytoma Local Doctors?
Elite in Pineocytoma
Radiation Oncology
Elite in Pineocytoma
Radiation Oncology
Referral may be required

Adult Neurofibromatosis Type 1 (NF1) And Schwannomatosis Clinic

400 Parnassus Ave., Eighth Floor, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target. Raleigh earned a bachelor's degree in molecular and cell biology as well as a bachelor's degree in cognitive science from the University of California, Berkeley. He earned his doctoral degree in molecular pathogenesis – how disease develops at the molecular level – from the University of Chicago, followed by his medical degree from the Pritzker School of Medicine at the University of Chicago. He completed a residency in radiation oncology at UCSF. Raleigh is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, Pacific Pediatric Neuro-Oncology Consortium, Children's Oncology Group, Society for Neuro-Oncology, International Meningioma Society and North American Skull Base Society. At the UCSF Brain Tumor Center, Raleigh is a principal investigator with the Wolfe Meningioma Program Project. Dr. Raleigh is rated as an Elite provider by MediFind in the treatment of Pineocytoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri. Dr. Raleigh is board certified in American Board Of Radiology, Radiation Oncology. Dr. Raleigh is currently accepting new patients.

Elite in Pineocytoma
Elite in Pineocytoma
Referral may be required
Groupement Hospitalier Est, 
Bron, FR 

Carmine Mottolese practices practicing medicine in Bron, France. Mr. Mottolese is rated as an Elite expert by MediFind in the treatment of Pineocytoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Plagiocephaly, Metopic Ridge, Awake Craniotomy, and Craniectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pineocytoma
Elite in Pineocytoma
Referral may be required
Groupement Hospitalier Est, 
Bron, FR 

Alexandru Szathmari practices practicing medicine in Bron, France. Mr. Szathmari is rated as an Elite expert by MediFind in the treatment of Pineocytoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Plagiocephaly, Metopic Ridge, Awake Craniotomy, and Craniectomy.

What are the latest Pineocytoma Clinical Trials?
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Summary: This is an open-label phase 1 safety and feasibility study that will employ multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA) derived from a patient's primary brain tumor tissues. Young patients with embryonal central nervous system (CNS) malignancies typically are unable to receive irradiation due ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Pilot Study of Intrathecal Topotecan and Maintenance Chemotherapy in the Post-consolidation Setting for the Treatment of High-risk Embryonal Central Nervous System Tumours in Children Less Than 6 Years of Age

Summary: Pilot study to determine feasibility of adding intrathecal chemotherapy and maintenance therapy after high dose chemotherapy for treatment of newly diagnosed HR-EBTs in patients less than 6 years of age.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center